EP1944018A1 — Micronised particles of low-dosage strength active agents for powder formulations for inhalation
Assigned to Chiesi Farmaceutici SpA · Expires 2008-07-16 · 18y expired
What this patent protects
The invention relates to micronised particles of a low-dosage strength active ingredient to be used in dry powder formulations for inhalation and methods for preparing them. In particular the invention provides micronised particles of low-dosage strength active ingredients …
USPTO Abstract
The invention relates to micronised particles of a low-dosage strength active ingredient to be used in dry powder formulations for inhalation and methods for preparing them. In particular the invention provides micronised particles of low-dosage strength active ingredients which can easily and homogenously disperse in a dry powder formulation to be administered by means of a dry powder inhaler device. The invention is also directed to the formulations thereof in the form of powders for inhalation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.